AORT: Artivion, Inc.
About
Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.
Current Value
$26.871 Year Return
Current Value
$26.871 Year Return
Key Details
Market Cap
$1.13B
P/E Ratio
-1043.8
1Y Stock Return
69.69%
1Y Revenue Growth
13.29%
Dividend Yield
0.00%
Price to Book
3.7
Strategies that include AORT
Stock's related to AORT
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| GLDD | 52.42% | $828.12M | +90.26% | 0.00% |
| KFRC | 49.84% | $1.10B | -8.71% | 0.66% |
| EVCM | 47.07% | $2.06B | +33.33% | 0.00% |
| SW | 45.93% | $13.78B | +15.02% | 1.14% |
| NEWT | 45.13% | $364.85M | +5.72% | 5.42% |
| PLYM | 45.11% | $842.88M | -11.32% | 5.12% |
| BIGC | 44.86% | $473.42M | -31.75% | 0.00% |
| GOOD | 44.36% | $758.90M | +40.97% | 6.47% |
| OLP | 43.35% | $617.02M | +46.60% | 6.26% |
| JJSF | 42.89% | $3.21B | -0.70% | 1.81% |
| TY | 42.13% | - | - | 3.32% |
| KE | 42.00% | $469.43M | -24.37% | 0.00% |
| VCEL | 41.48% | $2.76B | +55.60% | 0.00% |
| IIIN | 40.98% | $574.03M | -5.28% | 0.41% |
| SIBN | 40.95% | $516.68M | -29.40% | 0.00% |
| CMCO | 40.48% | $1.03B | +3.66% | 0.78% |
| PRLB | 40.39% | $907.12M | +1.96% | 0.00% |
| TCMD | 40.08% | $378.43M | +24.66% | 0.00% |
| ALKT | 40.05% | $3.80B | +65.83% | 0.00% |
| INN | 39.97% | $661.35M | -1.61% | 4.92% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TBRG | -0.02% | $244.47M | +52.66% | 0.00% |
| TXO | -0.03% | $737.26M | -1.80% | 13.22% |
| GAN | -0.05% | $83.39M | +21.19% | 0.00% |
| ASPS | -0.12% | $22.36M | -80.26% | 0.00% |
| NGL | -0.14% | $572.94M | +5.60% | 0.00% |
| NRG | 0.14% | $19.22B | +109.87% | 1.71% |
| FATBB | -0.27% | $81.94M | -12.91% | 11.69% |
| CATX | 0.28% | $458.24M | +162.59% | 0.00% |
| NOC | 0.29% | $71.54B | +4.23% | 1.60% |
| DADA | -0.34% | $367.07M | -63.71% | 0.00% |
| IFRX | 0.35% | $113.06M | +31.51% | 0.00% |
| CME | -0.38% | $82.76B | +9.21% | 1.98% |
| IMNN | 0.41% | $10.02M | -22.89% | 0.00% |
| J | -0.49% | $16.59B | +27.85% | 0.86% |
| API | 0.51% | $299.01M | +33.12% | 0.00% |
| NAPA | 0.51% | $1.63B | +9.61% | 0.00% |
| MVO | 0.52% | $106.15M | -22.78% | 16.78% |
| CPB | 0.54% | $12.96B | +7.08% | 3.40% |
| RLMD | -0.55% | $89.92M | +1.36% | 0.00% |
| CCEC | 0.56% | $1.02B | +28.03% | 3.26% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HUSA | -16.20% | $16.69M | -11.56% | 0.00% |
| TPST | -12.58% | $37.75M | -77.59% | 0.00% |
| MNR | -12.40% | $1.66B | -10.71% | 15.90% |
| BTCT | -11.55% | $42.61M | +353.33% | 0.00% |
| STG | -10.10% | $35.67M | +7.92% | 0.00% |
| NEUE | -9.13% | $40.93M | -34.13% | 0.00% |
| PRPO | -8.50% | $9.10M | -13.65% | 0.00% |
| CIG.C | -7.34% | $2.48B | -3.55% | 0.00% |
| PGR | -7.02% | $149.10B | +57.29% | 0.45% |
| PULM | -6.53% | $19.83M | +202.98% | 0.00% |
| CORZ | -6.52% | $4.60B | +3,201.26% | 0.00% |
| EDSA | -6.32% | $7.11M | -21.79% | 0.00% |
| VIRT | -5.76% | $3.17B | +110.38% | 2.60% |
| LTM | -5.66% | $8.51B | -100.00% | <0.01% |
| LPTH | -5.34% | $62.27M | +33.05% | 0.00% |
| BACK | -5.33% | $1.76M | -32.90% | 0.00% |
| BP | -5.15% | $77.24B | -18.61% | 6.32% |
| RLX | -4.93% | $1.69B | -17.76% | 0.00% |
| CHD | -4.79% | $27.18B | +19.50% | 1.03% |
| MNOV | -4.62% | $93.19M | +2.15% | 0.00% |
ETF's related to AORT
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XHE | 59.44% | $213.41M | 0.35% |
| RSPA | 56.22% | $273.87M | 0% |
| SLYG | 54.55% | $3.69B | 0.15% |
| IWC | 54.19% | $933.99M | 0.6% |
| IJT | 54.18% | $6.64B | 0.18% |
| IWO | 53.91% | $12.56B | 0.24% |
| IWM | 53.82% | $75.73B | 0.19% |
| VTWO | 53.77% | $12.38B | 0.1% |
| NUSC | 53.54% | $1.27B | 0.31% |
| IJR | 53.48% | $90.05B | 0.06% |
| SMMV | 53.47% | $321.07M | 0.2% |
| SPSM | 53.40% | $12.72B | 0.03% |
| FSMD | 53.36% | $583.89M | 0.15% |
| ESML | 53.27% | $1.90B | 0.17% |
| PRFZ | 53.25% | $2.65B | 0.39% |
| XSMO | 53.16% | $1.25B | 0.39% |
| GSSC | 53.13% | $529.86M | 0.2% |
| VIOO | 53.06% | $3.12B | 0.1% |
| XSLV | 52.73% | $322.27M | 0.25% |
| SMMD | 52.62% | $1.24B | 0.15% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DBC | -0.22% | $1.39B | 0.87% |
| AGZD | -0.32% | $142.76M | 0.23% |
| BOXX | 0.39% | $4.43B | 0.1949% |
| UNG | -0.56% | $908.80M | 1.06% |
| BILZ | 0.76% | $563.02M | 0.14% |
| SGOV | 0.92% | $27.53B | 0.09% |
| TBIL | -1.09% | $4.38B | 0.15% |
| PDBC | -1.18% | $4.40B | 0.59% |
| ULST | 1.45% | $535.47M | 0.2% |
| MINT | 1.47% | $11.62B | 0.35% |
| COMT | -1.65% | $829.06M | 0.48% |
| HIGH | 1.72% | $302.78M | 0.51% |
| KCCA | 1.73% | $220.51M | 0.87% |
| CCOR | 1.74% | $109.04M | 1.18% |
| SOYB | -1.88% | $27.32M | 0.22% |
| BCI | 1.95% | $1.20B | 0.26% |
| FTGC | 2.02% | $2.17B | 1.02% |
| BCD | 2.36% | $245.02M | 0.3% |
| FTSM | 2.76% | $6.08B | 0.45% |
| XHLF | 2.91% | $874.27M | 0.03% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -32.58% | $388.04M | 1.43% |
| VIXY | -29.22% | $195.31M | 0.85% |
| TAIL | -24.46% | $67.98M | 0.59% |
| USDU | -15.80% | $201.97M | 0.5% |
| MSOS | -11.40% | $632.80M | 0.83% |
| KRBN | -11.13% | $242.47M | 0.85% |
| UUP | -11.08% | $309.25M | 0.77% |
| TPMN | -10.82% | $40.60M | 0.65% |
| KMLM | -9.21% | $353.87M | 0.9% |
| DBO | -8.89% | $217.57M | 0.77% |
| CORN | -8.46% | $61.12M | 0.2% |
| YEAR | -7.55% | $1.13B | 0.25% |
| DBE | -6.96% | $50.13M | 0.77% |
| CTA | -6.80% | $350.27M | 0.78% |
| JUCY | -6.71% | $324.29M | 0.6% |
| HDRO | -6.02% | $164.26M | 0.3% |
| EQLS | -5.53% | $76.08M | 1% |
| WEAT | -4.32% | $120.27M | 0.28% |
| GBIL | -3.96% | $5.60B | 0.12% |
| GSG | -3.04% | $914.42M | 0.75% |
News
Yahoo
Artivion ( NYSE:AORT ) Third Quarter 2024 Results Key Financial Results Revenue: US$95.8m (up 9.0% from 3Q 2023). Net...
SeekingAlpha
Artivion, Inc. (NYSE:AORT) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsDorothy Morgan - Gilmartin Group LLCPat Mackin -...
Finnhub
ATLANTA - Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the third quarter ended September 30, 2024.'We continued our...
Finnhub
KENNESAW, Ga. — KENNESAW, Ga. — Artivion, Inc. on Thursday reported a loss of $2.3 million in its third quarter. On a per-share basis, the Kennesaw, Georgia-based company said it had a loss...
Yahoo
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.
Yahoo
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2024 financial results will be released on Thursday, November 7, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.